Literature DB >> 21156107

[Children prefer bottled amoxicillin].

Anton Pottegård1, Jesper Hallas.   

Abstract

INTRODUCTION: We wanted to test whether we, by using data on thousands of prescriptions, could answer a prosaic yet very timely question: Which penicillin is most widely accepted?
MATERIAL AND METHODS: By use of the Odense PharmacoEpidemiological Database (OPED) we extracted data on all penicillin prescriptions issued to children in the Region of Southern Denmark in 2009. We calculated the rate of early switch, defined by redeeming a new penicillin prescription within three days. Such a switch was believed to reflect taste-related therapeutic failure.
RESULTS: We analysed 253,018 penicillin prescriptions issued to 90,054 children. Among the three analysed penicillin brands, Primcillin (phenoxymethylpenicillin mixture), Imacillin (amoxicillin mixture) and Flemoxin (amoxicillin soluble tablets), we found 2,599 early switches. The relative risk of switch for Primcillin and Flemoxin using Imacillin as reference was 14.7 and 3.3.
CONCLUSION: Phenoxymethylpenicillin is less accepted. Children prefer bottled amoxicillin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21156107

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN: 0041-5782


  3 in total

1.  Factors predicting antibiotic prescription and referral to hospital for children with respiratory symptoms: secondary analysis of a randomised controlled study at out-of-hours services in primary care.

Authors:  Ingrid Keilegavlen Rebnord; Hogne Sandvik; Anders Batman Mjelle; Steinar Hunskaar
Journal:  BMJ Open       Date:  2017-01-17       Impact factor: 2.692

2.  Trends in Antibiotic Use in Danish, Finnish, Norwegian and Swedish Children.

Authors:  Nils Skajaa; Lise Gehrt; Heta Nieminen; Ida Laake; Hélène Englund; Ute Wolff Sönksen; Berit Feiring; Christine Stabell Benn; Lill Trogstad; Arto A Palmu; Signe Sørup
Journal:  Clin Epidemiol       Date:  2022-08-07       Impact factor: 5.814

3.  Requests for new oral antibiotic prescriptions in children within 2 days: a Norwegian population-based study.

Authors:  E H Bergene; H Nordeng; T B Rø; A Steinsbekk
Journal:  Fam Pract       Date:  2018-12-12       Impact factor: 2.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.